Four figures, and the arithmetic holds
The plan grid gives a quarterly rate and a monthly rate for semaglutide and the same pair for tirzepatide. Each quarterly rate is printed as a per-month figure with the amount billed per quarter beside it in brackets.
We checked both divisions and they land within a cent. That sounds like a small thing and it is not: a seller whose own totals do not divide to its own printed rates has published a number nobody can act on, and this roster has several. This one is arithmetically honest.
Both molecules are also offered with B12 or glycine at the stated rate, and maintenance plans are named. The page prices what it sells.
The membership line
Beside the grid, one line reads transparent pricing with no hidden fees and no membership. Fifty-five of the one hundred and fifty-eight sellers here state that no membership fee applies, and stating it in the same block as the prices is the right place for it.
The Terms carry a dedicated section headed with the operating company's legal name, and state plainly that the company is not a medical provider, does not make clinical decisions and does not establish a provider-patient relationship. That is a clear division of responsibility, even though it means the clinical side is left unnamed.
What is missing
A first-order discount code sits in a bar at the top of every page. The published figures are the standing rates and the code is a reduction on the first order, so the first bill is lower than the record shows.
No compounding pharmacy is named: one hundred and twenty-six of the one hundred and fifty-eight sellers here name none. No individual clinician is named; seventy-six of the one hundred and fifty-eight name nobody who prescribes. No service area is published; eighty-two of the one hundred and fifty-eight publish none. There is no brand-name route.
Somira Health's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $136.66/moper month on the quarterly plan, $409.99 billed per quarter as printed beside the figure | September 2026source |
| Semaglutide (compounded) | $189.99/moper month on the month-to-month plan, available with B12 or glycine | September 2026source |
| Tirzepatide (compounded) | $166.66/moper month on the quarterly plan, $499.99 billed per quarter as printed beside the figure | September 2026source |
| Tirzepatide (compounded) | $239.99/moper month on the month-to-month plan | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See Somira Health's current price →Good fit if
- Readers who want both plan lengths priced for both drugs on one page.
- Buyers who want the billed quarterly total printed beside the per-month rate.
- People who want a plain statement that there is no membership fee.
Look elsewhere if
- Anyone who wants the compounding pharmacy or a prescribing clinician named.
- Readers who need a service-area list.
- Buyers looking for a brand-name route; there is none.
How this review was verified
- Re-read the weight-loss page and the terms of service on 6 September 2026, comparing the requested path to the effective path and running a nonsense path against the host in the same run.
- Divided each published quarterly total by three and confirmed it lands within a cent of the printed per-month figure, rather than assuming the seller's arithmetic.
- Recorded all four plan figures rather than the two cheapest.
- Read the membership statement from the line beside the plan grid and the entity from the section of the Terms headed with its legal name.
- Screened the operating entity and the brand name against FDA's live warning-letter record with a known letter as a positive control and a nonsense string as a negative control in the same pass. Neither returned a letter. Untitled letters are published separately and were not searched.